Oatly Group (NASDAQ:OTLY) CEO Sells $17,289.96 in Stock

Oatly Group AB Sponsored ADR (NASDAQ:OTLY) CEO Jean-Christophe Marie Flatin sold 1,934 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $8.94, for a total value of $17,289.96. Following the transaction, the chief executive officer owned 245,400 shares in the company, valued at approximately $2,193,876. The trade was a 0.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oatly Group Price Performance

OTLY opened at $8.19 on Friday. The stock’s 50 day simple moving average is $10.79 and its 200 day simple moving average is $11.16. The company has a debt-to-equity ratio of 43.43, a current ratio of 0.45 and a quick ratio of 0.32. Oatly Group AB Sponsored ADR has a 1 year low of $8.09 and a 1 year high of $18.84. The firm has a market cap of $255.77 million, a price-to-earnings ratio of -1.64 and a beta of 1.85.

Oatly Group (NASDAQ:OTLY) last posted its quarterly earnings results on Thursday, April 30th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.52. Oatly Group had a negative return on equity of 432.75% and a negative net margin of 17.06%.The business had revenue of $228.33 million for the quarter, compared to analyst estimates of $214.61 million. As a group, analysts predict that Oatly Group AB Sponsored ADR will post -2.77 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on OTLY shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Oatly Group in a research report on Friday, March 27th. Morgan Stanley set a $12.55 price objective on Oatly Group in a research report on Thursday, April 30th. Finally, Barclays set a $14.00 price objective on Oatly Group and gave the stock an “overweight” rating in a research report on Tuesday, April 14th. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $14.64.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Performa Ltd US LLC lifted its stake in shares of Oatly Group by 16.8% in the 4th quarter. Performa Ltd US LLC now owns 10,100 shares of the company’s stock valued at $108,000 after purchasing an additional 1,450 shares during the period. Van ECK Associates Corp raised its stake in Oatly Group by 19.0% during the third quarter. Van ECK Associates Corp now owns 11,001 shares of the company’s stock valued at $178,000 after buying an additional 1,756 shares during the last quarter. Geode Capital Management LLC purchased a new position in Oatly Group during the second quarter valued at $151,000. Cubist Systematic Strategies LLC purchased a new position in Oatly Group during the first quarter valued at $133,000. Finally, R Squared Ltd purchased a new position in Oatly Group during the fourth quarter valued at $155,000. Hedge funds and other institutional investors own 68.15% of the company’s stock.

Oatly Group Company Profile

Oatly Group is a Sweden-based food and beverage company specializing in the development, production and sale of oat-derived dairy alternatives. The company’s product lineup includes oat-based drinks, ice cream, yogurts, spreads and cooking creams, all marketed under the Oatly brand name. By leveraging proprietary processing technology, Oatly extracts the nutritional benefits of oats—such as soluble fiber and plant protein—while delivering taste and texture profiles that closely mimic traditional dairy products.

Founded in 1994 as a spin-off from research at Lund University, Oatly initially focused on exploiting the health and functional benefits of oat beta-glucans.